Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal 15-valent Conjugate Vaccine vs 13-valent Vaccine in Infants
CTR20200799Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 15-valent conjugate vaccine in invasive pneumococcal disease (IPD), sponsored by Zhifei Biological. Started Dec 2020; status: completed.
02
Drugs
pneumococcal 15-valent conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on CTR20200799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200799.